AQUILON PHARMACEUTICALS (Public limited company)
AQUILON PHARMACEUTICALS is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0540.870.218. It was founded on 16-10-2013. Its registered office is in Seraing. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 4 254 081 and a loss of € 444 073. These accounts report 8.7 full-time equivalents. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 09-10-2026.
Company information
Key figures of AQUILON PHARMACEUTICALS
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -444 073+51 % | € -913 660+2 % | € -936 675-23 % | € -762 477 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 4 254 081+228 % | € 1 296 242-30 % | € 1 863 008+145 % | € 760 758 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 11 105 882+8 % | € 10 306 004+5 % | € 9 784 947+25 % | € 7 815 276 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 1 257 251+27 % | € 991 768+8 % | € 917 235+103 % | € 451 097 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 8.7-7 % | 9.4+2 % | 9.2+12 % | 8.2 |
Financial estimate
- 3 Shareholders
- 3 Board links
Similar companies
Other companies in the same activity in Seraing.
| Company | Town |
|---|---|
| KANEKA EUROGENTEC | 4102 Seraing |
| UNISENSOR | 4102 Seraing |
| DIAGENODE | 4102 Seraing |
| WIELANDTS ULTRA PRECISION MACHINING TECHNOLOGIES | 4102 Seraing |
| SYNGULON | 4102 Seraing |
| AARDEX Group | 4102 Seraing |
| NEXT ENERGY | 4102 Seraing |
| Biocubik | 4102 Seraing |
Frequently asked questions
Is AQUILON PHARMACEUTICALS still active? Yes. The Crossroads Bank for Enterprises lists AQUILON PHARMACEUTICALS as active.
What is the VAT number of AQUILON PHARMACEUTICALS? The VAT number of AQUILON PHARMACEUTICALS is BE 0540.870.218.
When was AQUILON PHARMACEUTICALS founded? AQUILON PHARMACEUTICALS was founded on 16-10-2013.
What is the address of AQUILON PHARMACEUTICALS? The current registered office of AQUILON PHARMACEUTICALS is Rue du Bois St-Jean 15/1, 4102 Seraing.
When did AQUILON PHARMACEUTICALS last file annual accounts? The latest annual accounts of AQUILON PHARMACEUTICALS were filed on 22-07-2026.
Does AQUILON PHARMACEUTICALS file its annual accounts on time? Yes. AQUILON PHARMACEUTICALS filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does AQUILON PHARMACEUTICALS have? AQUILON PHARMACEUTICALS employs 8.7 full-time equivalents according to its most recent annual accounts.
Is AQUILON PHARMACEUTICALS financially healthy? Addrly gives AQUILON PHARMACEUTICALS a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is AQUILON PHARMACEUTICALS profitable? The annual accounts of AQUILON PHARMACEUTICALS for 2025 show a loss of € 444 073.
What is the equity of AQUILON PHARMACEUTICALS? The equity of AQUILON PHARMACEUTICALS was € 4 254 081 at the close of the 2025 financial year.
Who are the directors of AQUILON PHARMACEUTICALS? The annual accounts of AQUILON PHARMACEUTICALS record 13 mandates. The names, roles and dates are visible with a free account.
Can AQUILON PHARMACEUTICALS receive Peppol e-invoices? Yes. AQUILON PHARMACEUTICALS is registered on the Peppol network and can receive structured electronic invoices.
What does AQUILON PHARMACEUTICALS do? The main activity of AQUILON PHARMACEUTICALS is: Scientific research and development.